We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Machine Learning Technique Analyzes Electronic Health Records to Predict Mortality in COVID-19 Patients

By HospiMedica International staff writers
Posted on 19 Jan 2021
Illustration
Illustration
Researchers have used a machine learning technique called "federated learning" to examine electronic health records to better predict how COVID-19 patients will progress.

The researchers from the Mount Sinai Health System (New York, NY, USA) who built models using federated learning to enhance predictions of COVID-19 outcomes believe that the emerging technique holds promise to create more robust machine learning models that extend beyond a single health system without compromising patient privacy. These models, in turn, can help triage patients and improve the quality of their care.

Federated learning is a technique that trains an algorithm across multiple devices or servers holding local data samples but avoids clinical data aggregation, which is undesirable for reasons including patient privacy issues. Mount Sinai researchers implemented and assessed federated learning models using data from electronic health records at five separate hospitals within the Health System to predict mortality in COVID-19 patients. They compared the performance of a federated model against ones built using data from each hospital separately, referred to as local models. After training their models on a federated network and testing the data of local models at each hospital, the researchers found the federated models demonstrated enhanced predictive power and outperformed local models at most of the hospitals.

"Machine learning models in health care often require diverse and large-scale data to be robust and translatable outside the patient population they were trained on," said the study's corresponding author, Benjamin Glicksberg, PhD, Assistant Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, and member of the Hasso Plattner Institute for Digital Health at Mount Sinai and the Mount Sinai Clinical Intelligence Center. "Federated learning is gaining traction within the biomedical space as a way for models to learn from many sources without exposing any sensitive patient data. In our work, we demonstrate that this strategy can be particularly useful in situations like COVID-19."

"Machine learning in health care continues to suffer a reproducibility crisis," said the study's first author, Akhil Vaid, MD, postdoctoral fellow in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, and member of the Hasso Plattner Institute for Digital Health at Mount Sinai and the Mount Sinai Clinical Intelligence Center. "We hope that this work showcases benefits and limitations of using federated learning with electronic health records for a disease that has a relative dearth of data in an individual hospital. Models built using this federated approach outperform those built separately from limited sample sizes of isolated hospitals. It will be exciting to see the results of larger initiatives of this kind."

Related Links:
Mount Sinai Health System

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Half Apron
Demi

Channels

Surgical Techniques

view channel
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more